{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T17:19:43Z","timestamp":1778260783995,"version":"3.51.4"},"reference-count":36,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Artificial Organs"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The safety and impact of sodium glucose transporter 2 inhibitors (SGLT2\u2010I) in patients with left ventricular assist devices (LVAD) are unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective analysis of all consecutive patients who underwent LVAD Heart Mate 3 (HM3) implantation at a single medical center and received SGLT2\u2010I therapy following surgery was conducted. LVAD parameters, medical therapy, laboratory tests, echocardiography, and right heart catheterization (RHC) study results were recorded and compared before and after initiation of SGLT2\u2010I.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>SGLT2\u2010I medications were initiated in 29 (21%) of 138 patients following HM3 implantation (23 (79%) received Empagliflozin and 6 (21%) Dapagliflozin). The mean age at the time of LVAD implantation was 62\u2009\u00b1\u20096.7\u2009years, 25 (86%) were male, and 23 (79%) had diabetes mellitus. The median time from HM3 implantation to SGLT2\u2010I initiation was 108\u2009days, IQR (26\u2013477). Following SGLT2\u2010I therapy, the daily dose of furosemide decreased from 47 to 23.5\u2009mg\/day (mean difference\u2009=\u200923.5\u2009mg\/d, 95% CI 8.2\u201338.7, <jats:italic>p<\/jats:italic>\u2009=\u20090.004) and significant weight reduction was observed (mean difference 2.5\u2009kg, 95% CI 0.7\u20134.3, <jats:italic>p<\/jats:italic>\u2009=\u20090.008). Moreover, a significant 5.6\u2009mm\u2009Hg reduction in systolic pulmonary artery pressure (sPAP) was measured during RHC (95% CI 0.23\u201311, <jats:italic>p<\/jats:italic>\u2009=\u20090.042) in a subgroup of 11 (38%) patients. LVAD parameters were similar before and after SGLT2\u2010I initiation (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.2 for all). No adverse events were recorded during median follow\u2010up of 354\u2009days, IQR (206\u2013786).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>SGLT2\u2010I treatment is safe in LVAD patients and might contribute to reduction in patients sPAP.<\/jats:p><\/jats:sec>","DOI":"10.1111\/aor.14733","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T06:34:19Z","timestamp":1709015659000},"page":"902-911","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The safety of sodium glucose transporter 2 inhibitors and trends in clinical and hemodynamic parameters in patients with left ventricular assist devices"],"prefix":"10.1111","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4541-8366","authenticated-orcid":false,"given":"Alexander","family":"Fardman","sequence":"first","affiliation":[{"name":"The Cardiovascular Division Sheba Medical Center  Tel Hashomer Israel"},{"name":"The Sackler School of Medicine Tel\u2010Aviv University  Tel Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afek","family":"Kodesh","sequence":"additional","affiliation":[{"name":"The Sackler School of Medicine Tel\u2010Aviv University  Tel Aviv Israel"},{"name":"Department of Internal Medicine Montefiore Medical Center\/Albert Einstein College of Medicine  Bronx New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison Joyce","family":"Siegel","sequence":"additional","affiliation":[{"name":"The Sackler School of Medicine Tel\u2010Aviv University  Tel Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6653-7543","authenticated-orcid":false,"given":"Amitai","family":"Segev","sequence":"additional","affiliation":[{"name":"The Cardiovascular Division Sheba Medical Center  Tel Hashomer Israel"},{"name":"The Sackler School of Medicine Tel\u2010Aviv University  Tel Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehud","family":"Regev","sequence":"additional","affiliation":[{"name":"The Cardiovascular Division Sheba Medical Center  Tel Hashomer Israel"},{"name":"The Sackler School of Medicine Tel\u2010Aviv University  Tel Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elad","family":"Maor","sequence":"additional","affiliation":[{"name":"The Cardiovascular Division Sheba Medical Center  Tel Hashomer Israel"},{"name":"The Sackler School of Medicine Tel\u2010Aviv University  Tel Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anat","family":"Berkovitch","sequence":"additional","affiliation":[{"name":"The Cardiovascular Division Sheba Medical Center  Tel Hashomer Israel"},{"name":"The Sackler School of Medicine Tel\u2010Aviv University  Tel Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Kuperstein","sequence":"additional","affiliation":[{"name":"The Cardiovascular Division Sheba Medical Center  Tel Hashomer Israel"},{"name":"The Sackler School of Medicine Tel\u2010Aviv University  Tel Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avi","family":"Morgan","sequence":"additional","affiliation":[{"name":"The Cardiovascular Division Sheba Medical Center  Tel Hashomer Israel"},{"name":"The Sackler School of Medicine Tel\u2010Aviv University  Tel Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyal","family":"Nahum","sequence":"additional","affiliation":[{"name":"The Cardiovascular Division Sheba Medical Center  Tel Hashomer Israel"},{"name":"The Sackler School of Medicine Tel\u2010Aviv University  Tel Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yael","family":"Peled","sequence":"additional","affiliation":[{"name":"The Cardiovascular Division Sheba Medical Center  Tel Hashomer Israel"},{"name":"The Sackler School of Medicine Tel\u2010Aviv University  Tel Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avishay","family":"Grupper","sequence":"additional","affiliation":[{"name":"The Cardiovascular Division Sheba Medical Center  Tel Hashomer Israel"},{"name":"The Sackler School of Medicine Tel\u2010Aviv University  Tel Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,2,26]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1900486"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2021.02.010"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2022.11.023"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004628"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2021.12.011"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2019.4965"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2016.03.011"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911303"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022190"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107038"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206286"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368"},{"issue":"18","key":"e_1_2_8_14_1","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich PA","year":"2022","journal-title":"Circulation"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-020-0406-8"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-022-00824-4"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0000000000001531"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2023.131259"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.22066"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2731"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2017.06.001"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2019.12.007"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13520"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-021-00507-z"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2009.09.013"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2007.01.085"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.875204"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2006.08.104"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezs678"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2021.01.004"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12850"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.052503"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.33594\/000000178"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007046"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.045691"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2015.03.011"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2016.08.010"}],"container-title":["Artificial Organs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aor.14733","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T09:52:51Z","timestamp":1721641971000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/aor.14733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,26]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.1111\/aor.14733"],"URL":"https:\/\/doi.org\/10.1111\/aor.14733","archive":["Portico"],"relation":{},"ISSN":["0160-564X","1525-1594"],"issn-type":[{"value":"0160-564X","type":"print"},{"value":"1525-1594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,26]]},"assertion":[{"value":"2023-10-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}